BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 129 filers reported holding BIOSCRIP INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $317,000 | +95.7% | 88,735 | +60.3% | 0.02% | +185.7% |
Q2 2018 | $162,000 | +161.3% | 55,356 | +117.5% | 0.01% | +250.0% |
Q1 2018 | $62,000 | -66.8% | 25,456 | -62.7% | 0.00% | -80.0% |
Q3 2017 | $187,000 | +544.8% | 68,254 | +298.5% | 0.01% | +900.0% |
Q1 2017 | $29,000 | -71.8% | 17,128 | -57.8% | 0.00% | -80.0% |
Q2 2016 | $103,000 | -53.2% | 40,633 | -60.6% | 0.01% | -50.0% |
Q1 2016 | $220,000 | -76.5% | 103,214 | -51.2% | 0.01% | -68.8% |
Q1 2015 | $937,000 | +121.5% | 211,566 | +338.2% | 0.03% | +39.1% |
Q3 2013 | $423,000 | – | 48,285 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |